U.S. RESEARCH ROUNDUP-Autodesk, McKesson, Microstrategy

Reuters05-29

May 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Autodesk, McKesson and Microstrategy on Wednesday.

HIGHLIGHTS

* Analog Devices Inc : Raymond James raises target price to $260 from $215

* Autodesk Inc : Baird cuts target price to $289 from $296

* Cencora Inc : Baird raises target price to $280 from $277

* McKesson Corp : Baird raises target price to $679 from $671

* Microstrategy Inc : Canaccord Genuity raises target price to $2,047 from $1,590

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

* Agios Pharmaceuticals Inc : Leerink Partners raises target price to $59 from $49

* Akoustis Technologies Inc : Craig-Hallum cuts to hold rating

* Akoustis Technologies Inc : Craig-Hallum cuts target price to $0.25

* American Airlines : Jefferies cuts target price to $12 from $17

* American Airlines : Jefferies cuts to hold from buy

* Analog Devices Inc : Raymond James raises target price to $260 from $215

* Autodesk Inc : Baird cuts target price to $289 from $296

* Booz Allen Hamilton Holding Corp : Jefferies raises target price to $185 from $180

* Cardinal Health Inc : Baird raises target price to $129 from $128

* Caretrust REIT Inc : Raymond James raises target price to $29 from $27

* Caseys General Stores Inc : JP Morgan cuts target price to $298 from $299

* Cava Group Inc : TD Cowen raises target price to $90 from $73

* Cencora Inc : Baird raises target price to $280 from $277

* Cervomed Inc : Jonestrading initiates coverage with buy rating; target price $70

* Constellation Brands : Barclays cuts target price to $288 from $295

* Domo Inc : TD Cowen cuts target price to $8 from $10

* Duckhorn Portfolio Inc : RBC cuts target price to $11 from $14

* Hireright Holdings Corp : Jefferies raises target price to $14 from $11

* Ikena Oncology Inc : Wedbush cuts to neutral from outperform

* Ikena Oncology Inc : Wedbush cuts target price to $2 from $8

* Independent Bank Group Inc : Truist Securities cuts to hold from buy

* Independent Bank Group Inc : Truist Securities raises target to $50 from $46

* Insmed Inc : JP Morgan raises target price to $55 from $36

* Insmed Inc : TD Cowen raises target price to $67 from $45

* Insmed Inc : Truist Securities raises target price to $68 from $48

* Live Nation Entertainment Inc : JP Morgan cuts target price to $116 from $126

* McKesson Corp : Baird raises target price to $679 from $671

* Microstrategy Inc : Canaccord Genuity raises target price to $2,047 from $1,590

* Mind Medicine (Mindmed) Inc : Baird initiates with outperform rating; PT $27

* Molson Coors Beverage Company : Barclays cuts target price to $55 from $62

* Monro Inc : Jefferies cuts target price to $25 from $28

* MYR Group Inc : Baird cuts target price to $170 from $180

* Palomar Holdings Inc : Jefferies raises target price to $98 from $95

* Palomar Holdings Inc : KBW raises target price to $96 from $93

* PDF Solutions Inc : D.A. Davidson raises target price to $42 from $40

* RLJ Lodging Trust : Baird cuts target price to $13 from $14

* Rush Street Interactive Inc : Craig-Hallum raises target price to $11 from $10

* Sage Therapeutics Inc : Baird initiates coverage with neutral rating and $15 PT

* TKO Group : JP Morgan raises target price to $126 from $103

* Triumph Group Inc : TD Cowen cuts target price to $14 from $19.5

* Triumph Group Inc : TD Cowen cuts to hold from buy

* United Airlines : Jefferies raises target price to $65 from $54

* United Airlines : Jefferies raises to buy from hold

* Verastem Inc : Alliance Global Partners cuts target price to $20 from $34

* Xenia Hotels & Resorts Inc : Baird raises target price to $16 from $14

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment